Descripción

Curcumin safety data aggregated from ulcerative colitis trials indicate no serious adverse events attributable to the supplement. Mild gastrointestinal discomfort was occasionally reported.

Figure 35

Chart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 35: Curcumin safety data aggregated from ulcerative colitis trials indicate no serious adverse events attributable to the supplement. Mild gastrointestinal discomfort was occasionally reported.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Curcumin safety data aggregated from ulcerative colitis trials indicate no serious adverse events attributable to the supplement. Mild gastrointestinal discomfort was occasionally reported." />
  <figcaption>Figure 35. Curcumin safety data aggregated from ulcerative colitis trials indicate no serious adverse events attributable to the supplement. Mild gastrointestinal discomfort was occasionally reported.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Evidencia relacionada

Curcumin para Ulcerative Colitis (UC)

Calificación B · 5 estudios

Curcumin para Crohn's Disease

Calificación C · 3 estudios